Allergology: Food Allergy and Immunological Gastrointestinal Pathology

Allergology and Immunology · Clinical Specialties

How it begins

Un análisis exhaustivo de los mecanismos moleculares de la tolerancia oral, la ruptura de barrera epitelial, las alergias mediadas y no mediadas por IgE, enteropatías eosinofílicas y nuevas fronteras en inmunoterapia y diagnóstico de precisión.

What it covers

1. Immunobiology and Physiopathology of the Gastrointestinal Tract
2. · 1.1 Epithelial Barrier and GALT Integration
3. · 1.2 Oral Tolerance Mechanisms vs. Allergic Sensitization
4. Classification of Adverse Reactions to Foods
5. · 2.1 Immune Mechanism: IgE-Mediated, Non-IgE-Mediated and Mixed
6. · 2.2 Non-Immunological Intolerances (Enzymatic, Pharmacological and Idiopathic)
7. IgE-Mediated Food Allergies
8. · 3.1 Structure and Families of Trophallergens
9. · 3.2 Pathophysiology of Food Anaphylaxis and Clinical Syndromes
10. Mixed Gastrointestinal Pathologies (Eosinophilic Esophagitis and EGIDs)
11. · 4.1 Eosinophilic Esophagitis (EoE)
12. · 4.2 Gastritis, Gastroenteritis and Eosinophilic Colitis (non-EoE EGIDs)
13. Gastrointestinal Pathologies Not Mediated by IgE (Cellular)
14. · 5.1 FPIES (Food Protein-Induced Enterocolitis Syndrome)
15. · 5.2 FPIP (Food Protein-Induced Allergic Proctocolitis) and FPE (Enteropathy)
16. Celiac Disease and Wheat-Related Immune Disorders
17. · 6.1 Molecular Immunopathogenesis of Celiac Disease
18. · 6.2 Wheat Allergy Mediated by IgE and WDEIA
19. Advanced Diagnostic Protocol in Food Allergology
20. · 7.1 In vivo and in vitro Sensitization Tests and Component-Resolved Diagnosis (CRD)
21. · 7.2 Controlled Oral Provocation (POC) / Oral Food Challenge (OFC)
22. Therapeutic Strategies and Advanced Clinical Approach
23. · 8.1 Oral Immunotherapy (OIT) / Food Desensitization
24. · 8.2 Adjuvant Biological Therapies and Emergency Treatment
25. Primary Prevention of Food Allergy
26. · 9.1 Dual Allergen Exposure Hypothesis and Early Introduction
27. Differential Diagnoses and Complex Clinical Cases
28. · 10.1 Alpha-Gal Syndrome and Diamine Oxidase Deficiency (DAO)